Cargando…

Invasive Aspergillosis after Pandemic (H1N1) 2009

We report 2 patients with invasive aspergillosis after infection with pandemic (H1N1) 2009. Influenza viruses are known to cause immunologic defects and impair ciliary clearance. These defects, combined with high-dose corticosteroids prescribed during influenza-associated adult respiratory distress...

Descripción completa

Detalles Bibliográficos
Autores principales: Lat, Asma, Bhadelia, Nahid, Miko, Benjamin, Furuya, E. Yoko, Thompson, George R.
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086249/
https://www.ncbi.nlm.nih.gov/pubmed/20507748
http://dx.doi.org/10.3201/eid1606.100165
_version_ 1782202693069045760
author Lat, Asma
Bhadelia, Nahid
Miko, Benjamin
Furuya, E. Yoko
Thompson, George R.
author_facet Lat, Asma
Bhadelia, Nahid
Miko, Benjamin
Furuya, E. Yoko
Thompson, George R.
author_sort Lat, Asma
collection PubMed
description We report 2 patients with invasive aspergillosis after infection with pandemic (H1N1) 2009. Influenza viruses are known to cause immunologic defects and impair ciliary clearance. These defects, combined with high-dose corticosteroids prescribed during influenza-associated adult respiratory distress syndrome, may be novel risk factors predisposing otherwise immunocompetent patients to invasive aspergillosis.
format Text
id pubmed-3086249
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-30862492011-05-13 Invasive Aspergillosis after Pandemic (H1N1) 2009 Lat, Asma Bhadelia, Nahid Miko, Benjamin Furuya, E. Yoko Thompson, George R. Emerg Infect Dis Dispatch We report 2 patients with invasive aspergillosis after infection with pandemic (H1N1) 2009. Influenza viruses are known to cause immunologic defects and impair ciliary clearance. These defects, combined with high-dose corticosteroids prescribed during influenza-associated adult respiratory distress syndrome, may be novel risk factors predisposing otherwise immunocompetent patients to invasive aspergillosis. Centers for Disease Control and Prevention 2010-06 /pmc/articles/PMC3086249/ /pubmed/20507748 http://dx.doi.org/10.3201/eid1606.100165 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Lat, Asma
Bhadelia, Nahid
Miko, Benjamin
Furuya, E. Yoko
Thompson, George R.
Invasive Aspergillosis after Pandemic (H1N1) 2009
title Invasive Aspergillosis after Pandemic (H1N1) 2009
title_full Invasive Aspergillosis after Pandemic (H1N1) 2009
title_fullStr Invasive Aspergillosis after Pandemic (H1N1) 2009
title_full_unstemmed Invasive Aspergillosis after Pandemic (H1N1) 2009
title_short Invasive Aspergillosis after Pandemic (H1N1) 2009
title_sort invasive aspergillosis after pandemic (h1n1) 2009
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086249/
https://www.ncbi.nlm.nih.gov/pubmed/20507748
http://dx.doi.org/10.3201/eid1606.100165
work_keys_str_mv AT latasma invasiveaspergillosisafterpandemich1n12009
AT bhadelianahid invasiveaspergillosisafterpandemich1n12009
AT mikobenjamin invasiveaspergillosisafterpandemich1n12009
AT furuyaeyoko invasiveaspergillosisafterpandemich1n12009
AT thompsongeorger invasiveaspergillosisafterpandemich1n12009